Trends in end-of-life cancer care in the Medicare program

Journal of Geriatric Oncology
Shi-Yi WangCary P Gross

Abstract

To examine contemporary trends in end-of-life cancer care and geographic variation of end-of-life care aggressiveness among Medicare beneficiaries. Using the Surveillance, Epidemiology, and End Results-Medicare data, we identified 132,051 beneficiaries who died as a result of cancer in 2006-2011. Aggressiveness of end-of-life care was measured by chemotherapy received within 14 days of death, >1 emergency department (ED) visit within 30 days of death, >1 hospitalization within 30 days of death, ≥1 intensive care unit (ICU) admission within 30 days of death, in-hospital death, or hospice enrollment ≤3 days before death. Using hierarchical generalized linear models, we assessed potentially aggressive end-of-life care adjusting for patient demographics, tumor characteristics, and hospital referral region (HRR)-level market factors. The proportion of beneficiaries receiving at least one potentially aggressive end-of-life intervention increased from 48.6% in 2006 to 50.5% in 2011 (P<.001). From 2006 to 2011, increases were apparent in repeated hospitalization (14.1% vs. 14.8%; P=.01), repeated ED visits (34.3% vs. 36.6%; P<.001), ICU admissions (16.2% vs. 21.3%; P<.001), and late hospice enrollment (11.2% vs. 12.9%; P<.001), whereas...Continue Reading

References

Feb 7, 1998·Medical Care·A ElixhauserR M Coffey
May 20, 2000·Annals of Internal Medicine·K E SteinhauserJ A Tulsky
Mar 15, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Craig C EarleSusan Block
May 8, 2003·JAMA : the Journal of the American Medical Association·Ellen P McCarthyRussell S Phillips
Nov 10, 2004·Health Services Research·Laurence C BakerDean Sonneborn
Dec 9, 2004·JAMA : the Journal of the American Medical Association·Peter B BachColin B Begg
Feb 17, 2005·Journal of the National Cancer Institute·Joseph Lipscomb
Feb 17, 2005·Journal of the National Cancer Institute·Nancy L KeatingEdward Guadagnoli
Jun 30, 2005·International Journal for Quality in Health Care : Journal of the International Society for Quality in Health Care·Craig C EarleJohn Z Ayanian
Aug 9, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Craig C EarleJohn Z Ayanian
Oct 9, 2008·JAMA : the Journal of the American Medical Association·Alexi A WrightHolly G Prigerson
Nov 13, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Soko SetoguchiJennifer S Haas
Mar 16, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Thi H HoCraig C Earle
May 5, 2011·Journal of the American Geriatrics Society·Joan M TenoVincent Mor
Mar 28, 2012·Journal of Pain & Palliative Care Pharmacotherapy·UNKNOWN Institute of Medicine
Feb 7, 2013·JAMA : the Journal of the American Medical Association·Joan M TenoVincent Mor
Sep 26, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Ayal A AizerPaul L Nguyen
Oct 8, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Alexi A WrightNancy L Keating
Nov 12, 2014·JAMA : the Journal of the American Medical Association·Joan M Teno, Pedro L Gozalo
Jul 15, 2015·Journal of Palliative Medicine·Shi-Yi WangElizabeth Bradley
Jul 24, 2015·JAMA Oncology·Holly G PrigersonPaul K Maciejewski

❮ Previous
Next ❯

Citations

Sep 15, 2016·Journal of Palliative Medicine·Gabriel A BrooksJoseph O Jacobson
Jun 13, 2019·Journal of Palliative Care·Shanthi SivendranKristina Newport
Aug 6, 2019·Cancer·Kelly M TrevinoPaul R Duberstein
Feb 14, 2019·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·AnneMarthe MjelstadAntonis Valachis
Jul 18, 2020·JCO Oncology Practice·Fauzia RiazCary P Gross
Jul 15, 2020·International Journal of Environmental Research and Public Health·Jessica CerniHassan Hosseinzadeh
Feb 16, 2020·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Sara L DouglasEric Blackstone
Jan 4, 2021·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Amy J DavidoffCarolyn J Presley
Nov 30, 2019·Journal of Pain and Symptom Management·Maureen L SaphireAmy J Davidoff
Dec 29, 2020·Journal of the American Geriatrics Society·Risha GidwaniTodd H Wagner
Mar 23, 2021·JHEP Reports : Innovation in Hepatology·Victor de AvilaZobair M Younossi
Feb 24, 2018·Journal of Pain and Symptom Management·Ilona FridmanE Tory Higgins
Aug 25, 2021·The American Journal of Hospice & Palliative Care·Laura C PraterSeuli Bose-Brill
Aug 14, 2021·Health Services Research·Peiyin HungShi-Yi Wang
Aug 20, 2018·Journal of Pain and Symptom Management·Cara L McDermottSean D Sullivan
Nov 10, 2021·JAMA : the Journal of the American Medical Association·Raymond U OsarogiagbonDeborah Schrag

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.